ENHANCED MIGRAINE TREATMENTS BASED ON GHRELIN MIMETICS

摘要

The present invention provides a pharmaceutical composition comprising an effective amount of a ghrelin matrix or a pharmaceutically acceptable salt, hydrate or solvate thereof and a serotonin 5-HT _{1B/ 1D} receptor agonist, a tryptamine derivative, an ergoline derivative, a non- steroidal anti- At least one migraine treatment agent selected from the group consisting of a combination of agents for treating migraine and a method for treating migraine.